BioSpace News Archive

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB).

- Over 90% of Hernia Repair Patients Receiving HTX-011 Required No Opioids to Manage Their Postoperative Pain Through 72 hours After Surgery - [16-September-2020] SAN DIEGO , Sept. 16, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments

Data could support future efforts to make real-time CGM a standard tool for glycemic assessment in the hospital setting Real-world evidence will be gathered from healthcare providers and hospital institutions using real-time CGM with hospitalized patients SAN DIEGO--( BUSINESS WIRE )-- DexCom , Inc. ( NASDAQ:DXCM ), the leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today the first ever

Seqirus, a global leader in influenza prevention, today announced the publication of real-world evidence (RWE) on the company’s cell-based quadrivalent influenza vaccine (QIVc) in peer-reviewed medical journal Vaccine.

CANCERPREV Cross-Disciplinary Program Expands Knowledge of Cancer Development to Deliver New Insights into Prevention Strategies

AOTI Inc. announced today an eagerly anticipated expansion of its unique multi-modality Topical Wound Oxygen (TWO2) therapy product family.

Neogen Corporation (NASDAQ: NEOG) announced today that it has launched an improved test that rapidly detects gluten in food products, raw ingredients, and environmental samples. Neogen’s new Reveal ® 3-D for Gluten screens samples at 5 parts per million (ppm) gluten in just 5 minutes. The new test streamlines the testing pr

Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Rebecca McNamara as Chief Financial Officer (CFO) reporting directly to Dave Fitzhenry, Trinity’s CEO.

Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), today announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 7,000,000 shares of the Company’s common stock (the “Offering”) at a price to the public of $59.75 per share.

OneOncology, the national partnership of independent oncology practices, today added two new senior healthcare executives to its leadership team with the appointment of Janice Baker as Chief Human Resources Officer and Jon Billington as Chief Financial Officer.